Repurposing beta-3 adrenergic receptor agonists for Alzheimer’s disease: beneficial effects in a mouse model
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Repurposing beta-3 adrenergic receptor agonists for Alzheimer’s disease: beneficial effects in a mouse model
Authors
Keywords
-
Journal
Alzheimers Research & Therapy
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-05-22
DOI
10.1186/s13195-021-00842-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The β3-adrenergic receptor agonist mirabegron improves glucose homeostasis in obese humans
- (2020) Brian S. Finlin et al. JOURNAL OF CLINICAL INVESTIGATION
- Effect of mirabegron on cognitive function in elderly patients with overactive bladder: MoCA results from a phase 4 randomized, placebo-controlled study (PILLAR)
- (2020) Tomas L. Griebling et al. BMC Geriatrics
- Safety and Tolerability Results from the PILLAR Study: A Phase IV, Double-Blind, Randomized, Placebo-Controlled Study of Mirabegron in Patients ≥ 65 years with Overactive Bladder-Wet
- (2020) Sender Herschorn et al. DRUGS & AGING
- High cholesterol triggers white matter alterations and cognitive deficits in a mouse model of cerebrovascular disease: benefits of simvastatin
- (2019) Xin-Kang Tong et al. Cell Death & Disease
- Repeated cold exposures protect a mouse model of Alzheimer's disease against cold-induced tau phosphorylation
- (2019) Marine Tournissac et al. Molecular Metabolism
- Evidence for brain glucose dysregulation in Alzheimer's disease
- (2018) Yang An et al. Alzheimers & Dementia
- Browning of white adipose tissue induced by the ß3 agonist CL-316,243 after local and systemic treatment - PK-PD relationship
- (2018) Wojciech Danysz et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Regulation of Human Adipose Tissue Activation, Gallbladder Size, and Bile Acid Metabolism by a β3-Adrenergic Receptor Agonist
- (2018) Alison S. Baskin et al. DIABETES
- Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums
- (2018) Steven E. Arnold et al. Nature Reviews Neurology
- The effects of exercise on hypothalamic neurodegeneration of Alzheimer’s disease mouse model
- (2018) Khoa Do et al. PLoS One
- Acute metabolic and cardiovascular effects of mirabegron in healthy individuals
- (2018) Rebecca K. C. Loh et al. DIABETES OBESITY & METABOLISM
- 3xTg-AD Mice Exhibit an Activated Central Stress Axis During Early-Stage Pathology
- (2018) Elaine K. Hebda-Bauer et al. JOURNAL OF ALZHEIMERS DISEASE
- Association of Neuropathological Markers in the Parietal Cortex With Antemortem Cognitive Function in Persons With Mild Cognitive Impairment and Alzheimer Disease
- (2017) Cyntia Tremblay et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Intranasal insulin improves cerebral blood flow, Nrf-2 expression and BDNF in STZ (ICV)-induced memory impaired rats
- (2017) N. Rajasekar et al. LIFE SCIENCES
- Old age potentiates cold-induced tau phosphorylation: linking thermoregulatory deficit with Alzheimer's disease
- (2017) Marine Tournissac et al. NEUROBIOLOGY OF AGING
- Mirabegron for the treatment of overactive bladder: a review of efficacy, safety and tolerability with a focus on male, elderly and antimuscarinic poor-responder populations, and patients with OAB in Asia
- (2017) Christopher R Chapple et al. Expert Review of Clinical Pharmacology
- Insulin deprivation induces PP2A inhibition and tau hyperphosphorylation in hTau mice, a model of Alzheimer’s disease-like tau pathology
- (2017) Maud Gratuze et al. Scientific Reports
- The role of the brown adipose tissue in β3-adrenergic receptor activation-induced sleep, metabolic and feeding responses
- (2017) Éva Szentirmai et al. Scientific Reports
- Metabolic activity of brown, “beige,” and white adipose tissues in response to chronic adrenergic stimulation in male mice
- (2016) Sébastien M. Labbé et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Combatting type 2 diabetes by turning up the heat
- (2016) Patrick Schrauwen et al. DIABETOLOGIA
- The amyloid hypothesis of Alzheimer's disease at 25 years
- (2016) Dennis J Selkoe et al. EMBO Molecular Medicine
- Beta3-adrenoreceptor agonist mirabegron – a potential antiobesity drug?
- (2016) Vojtech Hainer EXPERT OPINION ON PHARMACOTHERAPY
- Alzheimer's disease
- (2016) Philip Scheltens et al. LANCET
- Defeating Alzheimer's disease and other dementias: a priority for European science and society
- (2016) Bengt Winblad et al. LANCET NEUROLOGY
- Impaired thermoregulation and beneficial effects of thermoneutrality in the 3×Tg-AD model of Alzheimer's disease
- (2016) Milene Vandal et al. NEUROBIOLOGY OF AGING
- High fat diet exacerbates Alzheimer’s disease-related pathology in APPswe/PS1 mice
- (2016) Peter Thériault et al. Oncotarget
- A Comprehensive Behavioral Test Battery to Assess Learning and Memory in 129S6/Tg2576 Mice
- (2016) Andrea Wolf et al. PLoS One
- Activation of Human Brown Adipose Tissue by a β3-Adrenergic Receptor Agonist
- (2015) Aaron M. Cypess et al. Cell Metabolism
- Ectopic UCP1 Overexpression in White Adipose Tissue Improves Insulin Sensitivity in Lou/C Rats, a Model of Obesity Resistance
- (2015) Anne-Laure Poher et al. DIABETES
- Age-dependent impairment of glucose tolerance in the 3xTg-AD mouse model of Alzheimer’s disease
- (2015) Milene Vandal et al. FASEB JOURNAL
- Short-term cold acclimation improves insulin sensitivity in patients with type 2 diabetes mellitus
- (2015) Mark J W Hanssen et al. NATURE MEDICINE
- Tau and neurodegenerative disease: the story so far
- (2015) Khalid Iqbal et al. Nature Reviews Neurology
- The beta-3 adrenergic agonist (CL-316,243) restores the expression of down-regulated fatty acid oxidation genes in type 2 diabetic mice
- (2015) Amit Kumar et al. Nutrition & Metabolism
- Anti-obesity and metabolic efficacy of the β3-adrenergic agonist, CL316243, in mice at thermoneutrality compared to 22°C
- (2015) Cuiying Xiao et al. Obesity
- Role of Energy Metabolism in the Brown Fat Gene Program
- (2015) Minwoo Nam et al. Frontiers in Endocrinology
- Genetic Ablation of Tau Mitigates Cognitive Impairment Induced by Type 1 Diabetes
- (2014) Serena Abbondante et al. AMERICAN JOURNAL OF PATHOLOGY
- Insulin Reverses the High-Fat Diet-Induced Increase in Brain A and Improves Memory in an Animal Model of Alzheimer Disease
- (2014) M. Vandal et al. DIABETES
- Repurposing Diabetes Drugs for Brain Insulin Resistance in Alzheimer Disease
- (2014) M. Yarchoan et al. DIABETES
- Peroxisome Proliferator-Activated Receptor-Gamma Agonists for Alzheimer’s Disease and Amnestic Mild Cognitive Impairment: A Systematic Review and Meta-Analysis
- (2014) Jia Liu et al. DRUGS & AGING
- Mirabegron 50 mg once-daily for the treatment of symptoms of overactive bladder: An overview of efficacy and tolerability over 12 weeks and 1 year
- (2014) Christopher R Chapple et al. INTERNATIONAL JOURNAL OF UROLOGY
- IVIg protects the 3xTg-AD mouse model of Alzheimer’s disease from memory deficit and Aβ pathology
- (2014) Isabelle St-Amour et al. Journal of Neuroinflammation
- Altered cerebral vascular volumes and solute transport at the blood–brain barriers of two transgenic mouse models of Alzheimer's disease
- (2014) Tuan Minh Do et al. NEUROPHARMACOLOGY
- Characterization and Molecular Profiling of PSEN1 Familial Alzheimer's Disease iPSC-Derived Neural Progenitors
- (2014) Andrew A. Sproul et al. PLoS One
- UCP1 mRNA does not produce heat
- (2013) Jan Nedergaard et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Brown and beige fat: development, function and therapeutic potential
- (2013) Matthew Harms et al. NATURE MEDICINE
- Object recognition test in mice
- (2013) Marianne Leger et al. Nature Protocols
- Alzheimer disease in the United States (2010-2050) estimated using the 2010 census
- (2013) L. E. Hebert et al. NEUROLOGY
- Mirabegron in overactive bladder: A review of efficacy, safety, and tolerability
- (2013) Christopher R. Chapple et al. NEUROUROLOGY AND URODYNAMICS
- The Genetics of Alzheimer Disease
- (2013) R. E. Tanzi Cold Spring Harbor Perspectives in Medicine
- Impaired Satiation and Increased Feeding Behaviour in the Triple-Transgenic Alzheimer's Disease Mouse Model
- (2012) Adedolapo Adebakin et al. PLoS One
- Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment
- (2011) Suzanne Craft ARCHIVES OF NEUROLOGY
- The Physiological Link between Metabolic Rate Depression and Tau Phosphorylation in Mammalian Hibernation
- (2011) Jens T. Stieler et al. PLoS One
- DHA Improves Cognition and Prevents Dysfunction of Entorhinal Cortex Neurons in 3xTg-AD Mice
- (2011) Dany Arsenault et al. PLoS One
- Challenges in β3-adrenoceptor agonist drug development
- (2011) Jonathan R. S. Arch Therapeutic Advances in Endocrinology and Metabolism
- Regional cerebral glucose uptake in the 3xTG model of Alzheimer's disease highlights common regional vulnerability across AD mouse models
- (2010) Rachel M. Nicholson et al. BRAIN RESEARCH
- Characterization of the 3xTg-AD mouse model of Alzheimer's disease: Part 1. Circadian changes
- (2010) Roxanne Sterniczuk et al. BRAIN RESEARCH
- The β3 adrenoceptor agonist, amibegron (SR58611A) counteracts stress-induced behavioral and neurochemical changes
- (2010) Alessandra Tamburella et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Transgenic conversion of omega-6 into omega-3 fatty acids in a mouse model of Parkinson's disease
- (2010) Melanie Bousquet et al. JOURNAL OF LIPID RESEARCH
- Longitudinal Examination of Obesity and Cognitive Function: Results from the Baltimore Longitudinal Study of Aging
- (2010) John Gunstad et al. NEUROEPIDEMIOLOGY
- Alzheimer's Disease
- (2010) Henry W. Querfurth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and A deposition in an Alzheimer mouse model with diabetes
- (2010) S. Takeda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Synaptic degeneration in Alzheimer’s disease
- (2009) Thomas Arendt ACTA NEUROPATHOLOGICA
- Current Alzheimer's disease clinical trials: Methods and placebo outcomes
- (2009) Lon S. Schneider et al. Alzheimers & Dementia
- Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer's disease
- (2009) Fanchon Bourasset et al. NEUROPHARMACOLOGY
- Functional Brown Adipose Tissue in Healthy Adults
- (2009) Kirsi A. Virtanen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification and Importance of Brown Adipose Tissue in Adult Humans
- (2009) Aaron M. Cypess et al. NEW ENGLAND JOURNAL OF MEDICINE
- Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease
- (2008) Ying Liu et al. FEBS LETTERS
- Decreased drebrin mRNA expression in Alzheimer disease: Correlation with tau pathology
- (2008) Carl Julien et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Memory loss caused by β-amyloid protein is rescued by a β3-adrenoceptor agonist
- (2008) Marie E. Gibbs et al. NEUROBIOLOGY OF AGING
- High-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model
- (2008) Carl Julien et al. NEUROBIOLOGY OF AGING
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started